MYO3B promotes cancer progression in endometrial cancer by mediating the calcium ion-RhoA/ROCK1 signaling pathway
MYO3B promotes the proliferation and migration of endometrial cancer cells via Ca<sup>2+</sup>-RhoA/ROCK1 signaling pathway. High expression of MYO3B may be a biomarker for EC metastasis.
Authors
- Yuanyuan Ding (ORCID: https://orcid.org/0000-0003-2370-7642)
- Jiaolin Yang
- Xiaofeng Yang (ORCID: https://orcid.org/0000-0001-9023-5855)
- Chunmei Zhang (ORCID: https://orcid.org/0000-0003-0485-177X)
- Huifeng Zhang
- Sufen Li (ORCID: https://orcid.org/0000-0002-2695-8263)
- Xinglin Zhang
- Huancheng Su
- Bao Qiang (ORCID: https://orcid.org/0009-0001-9899-110X)
- Liang Wang (ORCID: https://orcid.org/0009-0009-7673-7272)
- Sanyuan Zhang
Institutions
- Shanxi Medical University (CN)
- Wuxi Municipal Product Quality Supervision and Inspection Institute (CN)
- First Hospital of Shanxi Medical University (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1007/s00432-024-05940-x
- Citations
- 8
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 2.28
Funders
- Natural Science Foundation of Shanxi Province